Nuzenio

Gene Technology Shareholders

Gene Technology Shareholders news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Bio-Gene Technology Seeks ASX Quotation for 15.22 Million SPP Underwriter Shares at $0.025 Each - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 06:01:03 GMTFMR Resources Shareholders Pass All Resolutions at General Meeting - KalkineKalkine · Mon, 10 Aug 2026 04:03:12 GMTBio-Gene Technology Issues 69.2 Million Unquoted Options Expiring October 2027 - KalkineKalkine · Mon, 10 Aug 2026 03:59:55 GMTBio-Gene Technology Directors Timothy Grogan and Andrew Guthrie Acquire Shares and Options Under Placement - KalkineKalkine · Mon, 10 Aug 2026 03:41:32 GMTBio-Gene Technology Applies to Quote 15.22 Million SPP Underwriter Shares at $0.025 - KalkineKalkine · Mon, 10 Aug 2026 03:08:13 GMTBio-Gene Technology Seeks ASX Listing for 34.76 Million Shares at $0.025 Each - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 03:08:13 GMTikeGPS Group Issues 31,832 Shares to Directors as Compensation - KalkineKalkine · Mon, 10 Aug 2026 02:34:07 GMTSK Hynix to announce additional shareholder return measures in third quarter - The StarThe Star · Fri, 07 Aug 2026 07:17:00 GMT

Timeline

Mon, 10 Aug 2026 06:01:03 GMTBio-Gene Technology Seeks ASX Quotation for 15.22 Million SPP Underwriter Shares at $0.025 Each - Kalkine Media
Mon, 10 Aug 2026 04:03:12 GMTFMR Resources Shareholders Pass All Resolutions at General Meeting - Kalkine
Mon, 10 Aug 2026 03:59:55 GMTBio-Gene Technology Issues 69.2 Million Unquoted Options Expiring October 2027 - Kalkine
Mon, 10 Aug 2026 03:41:32 GMTBio-Gene Technology Directors Timothy Grogan and Andrew Guthrie Acquire Shares and Options Under Placement - Kalkine
Mon, 10 Aug 2026 03:08:13 GMTBio-Gene Technology Applies to Quote 15.22 Million SPP Underwriter Shares at $0.025 - Kalkine
Mon, 10 Aug 2026 03:08:13 GMTBio-Gene Technology Seeks ASX Listing for 34.76 Million Shares at $0.025 Each - Kalkine Media

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Gene Technology Shareholders.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.